Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
Delayed Xetra  -  11:35 2022-10-06 am EDT
47.71 EUR   -1.94%
10/05Bayer Completes $2.6 Billion Sale of Environmental Science Professional Unit
MT
10/05Bayer : completes sale of its Environmental Science Professional business to Cinven
PU
10/03Optus Confirms More Than Two Million Customers' Identity Documents Affected by Hack
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about BAYER AG
10/05Bayer Completes $2.6 Billion Sale of Environmental Science Professional Unit
MT
10/05Bayer : completes sale of its Environmental Science Professional business to Cinven
PU
09/26Bayer Gets Japanese Regulatory Nod For Eye Drug in Preterm Infants
MT
09/20BAYER AG : Goldman Sachs maintains a Buy rating
MD
09/20BAYER AG : JP Morgan reaffirms its Buy rating
MD
09/20Bayer : to present new cardiorenal data for Kerendia™ (finerenone) across a broad ra..
PU
09/15Bayer CEO says supply shortages cut crop protection sales in 2022
RE
09/15Transcript : Bayer Aktiengesellschaft - Special Call
CI
09/15BAYER AG : Bernstein gives a Buy rating
MD
09/13BAYER AG : Buy rating from Bernstein
MD
09/13Germany's Bayer Starts Looking for New CEO
MT
09/13Bayer Begins Search for CEO Werner Baumann's Successor, Bloomberg Reports
DJ
09/13BAYER AG : Bernstein reiterates its Buy rating
MD
09/11Bayer : New ARASENS data reinforce strong tolerability profile of darolutamide plus ADT an..
PU
09/09Bayer AG - Aflibercept 8 mg first to achieve extended injection intervals of 16 weeks i..
AQ
More most relevant news
All news about BAYER AG
10/05Bayer Completes $2.6 Billion Sale of Environmental Science Professional Unit
MT
10/05Bayer : completes sale of its Environmental Science Professional business to Cinven
PU
10/03Optus Confirms More Than Two Million Customers' Identity Documents Affected by Hack
DJ
10/02Optus Hires Deloitte to Review Cyberattack
DJ
10/01Reuters-schedule/…
RE
09/28Bayer CropScience Gets Board Nod to Sell Environmental Science Business for Nearly $14 ..
MT
09/27Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Exten..
AQ
09/27Santen Pharmaceutical Co., Ltd. - Ophthalmic VEGF inhibitor Eylea Solution for Intravit..
AQ
09/26Australia's No. 2 telco Optus, government clash over massive data breach
RE
09/26U.S. farmers urge Washington to challenge Mexico's looming ban on GM corn
RE
More news
News in other languages on BAYER AG
10/05Bayer : achève la vente d'une activité à Cinven
10/05Bayer conclut la vente de l'unité professionnelle des sciences de l'environnement pour ..
10/04Bayer boekt weer juridisch succes
09/28DAX-Chefs verdienen 24 Prozent mehr - Vergütungstransparenz sinkt
09/26Bayer obtient le feu vert des autorités japonaises pour un médicament oculaire destiné ..
09/26Bayer : traitement par Elyea autorisé au Japon
09/23Pvr : Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der e..
09/22Energia: Ahk Italien, supportare rinnovabili per favorire transizione green
09/22Pvr : Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der e..
09/22Optus prévient qu'une cyberattaque pourrait avoir exposé les coordonnées de clients aus..
More news
Analyst Recommendations on BAYER AG
09/20BAYER AG : Goldman Sachs maintains a Buy rating
MD
09/20BAYER AG : JP Morgan reaffirms its Buy rating
MD
09/15BAYER AG : Bernstein gives a Buy rating
MD
09/13BAYER AG : Buy rating from Bernstein
MD
09/13BAYER AG : Bernstein reiterates its Buy rating
MD
More recommendations
Press releases
10/05Bayer : completes sale of its Environmental Science Professional business to Cinven
PU
09/27Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Exten..
AQ
09/27Santen Pharmaceutical Co., Ltd. - Ophthalmic VEGF inhibitor Eylea Solution for Intravit..
AQ
09/20Fitch Affirms Elanco's IDR at 'BB'; Outlooks Remains Negative
AQ
09/20Bayer : to present new cardiorenal data for Kerendia™ (finerenone) across a broad ra..
PU
More press releases
Upcoming event on BAYER AG